March 27th 2024
A nomogram that combines contrast-enhanced lymphatic ultrasound and grayscale ultrasound findings had an 88 percent AUC for prediction of three or more metastatic axillary lymph nodes in women with early breast cancer.
FDA Clears Mini Transesophageal Echocardiography Ultrasound Transducer
January 31st 2024Reportedly providing enhanced imaging of structural heart disease, the minimally invasive X11 4t Mini 3D TEE ultrasound transducer facilitates use of the technology in smaller pediatric patients as well as high-risk ICU patients.
FDA Grants De Novo Clearance for Ultrasound-Based Liver Tumor Ablation Software
January 8th 2024The BioTraceIO software reportedly facilitates visualization of liver tumor ablation procedures based on real-time ultrasound imaging and provides superior post-op estimates of ablation zone volume in comparison to computed tomography.
Can ChatGPT and Bard Bolster Decision-Making for Cancer Screening in Radiology?
December 21st 2023In a study examining the potential of the large language models ChatGPT-4 and Bard to follow ACR Appropriateness Criteria for breast cancer, lung cancer, ovarian cancer and colorectal cancer screening, researchers noted “impressive accuracy in making radiologic clinical decisions.”
Samsung Debuts New Ultrasound Modality Geared Toward Women's Health and Urology
November 15th 2023Combining enhanced imaging capabilities, workflow efficiencies and artificial intelligence (AI)-enabled technology to improve the diagnosis and management of health conditions in women, Samsung has launched the V6 ultrasound system.
Outpatient Reimbursement to Increase 65 Percent for EchoGo Heart Failure Platform in 2024
November 8th 2023Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.